Categories LATEST, Other Industries

General Electric gets an upgrade from Barclays

General Electric’s (GE) stock was given a rating of Overweight by Barclays who set its price target at $16. Last week, RBC Capital had given the stock a rating of Outperform with a price target of $15. The upgrades come amid significant changes at GE which are giving analysts optimism of a positive turnaround at the company.

GE has been struggling for a while now with slow sales and stock declines. The company lost its position on the Dow Jones index to Walgreens Boots Alliance (WBA) in June and has put several of its divisions up for sale during the year.

As part of its efforts to focus on aviation, power and renewable energy, the company revealed its plans to offload its healthcare, software, finance and insurance divisions along with its stake in Baker Hughes. GE also decided to divest parts of its industrial and power units in order to streamline its operations.

Analysts believe that under a new leadership, GE has a lot of options to explore in terms of restructuring and for ways to improve profits

Last week, in a surprise turn of events, GE replaced John Flannery with Larry Culp as CEO and the stock rallied 16% on the news. Analysts believe that the new chief has the potential to turn things around significantly. After a reduction in guidance for earnings and free cash flow along with a widely-anticipated dividend cut, it appears things can only get better now.

Analysts believe that under a new leadership, GE has a lot of options to explore in terms of restructuring and for ways to improve profits. On Friday, the stock saw a rally after details of the new CEO’s pay package were disclosed. Culp stands to make $300 million if he is able to push GE’s stock price to 150% over the next four years.

As of 1:50 pm ET, GE’s shares were up over 2%.

General Electric hits 9-year low amidst divestiture spree

Most Popular

United Parcel Service (UPS) seems on track to regain lost strength

Cargo giant United Parcel Service, Inc. (NYSE: UPS) ended fiscal 2023 on a weak note, reporting lower revenues and profit for the fourth quarter. The company experienced a slowdown post-pandemic

IPO Alert: What to look for when Boundless Bio goes public

Boundless Bio is preparing to debut on the Nasdaq stock market this week, and become the latest addition to the list of biotech firms that have launched IPOs this year.

Nike (NKE) bets on innovation and partnerships to return to high growth

Sneaker giant Nike, Inc. (NYSE: NKE) has been going through a rough patch for some time, with sales coming under pressure from weak demand and rising competition. Post-pandemic, the company

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top